IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 86 filers reported holding IMMUNOMEDICS INC in Q4 2014. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,231,000 | +139.9% | 26,237 | 0.0% | 0.01% | +140.0% |
| Q2 2020 | $930,000 | +162.7% | 26,237 | 0.0% | 0.01% | +150.0% |
| Q1 2020 | $354,000 | -21.7% | 26,237 | +22.9% | 0.00% | -33.3% |
| Q4 2019 | $452,000 | +59.7% | 21,350 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $283,000 | -4.4% | 21,350 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $296,000 | -27.8% | 21,350 | 0.0% | 0.00% | -33.3% |
| Q1 2019 | $410,000 | +34.4% | 21,350 | 0.0% | 0.00% | +50.0% |
| Q4 2018 | $305,000 | -31.5% | 21,350 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $445,000 | -11.9% | 21,350 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $505,000 | +61.9% | 21,350 | 0.0% | 0.00% | +50.0% |
| Q1 2018 | $312,000 | -35.0% | 21,350 | -28.1% | 0.00% | -33.3% |
| Q4 2017 | $480,000 | +15.7% | 29,684 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $415,000 | -2.4% | 29,684 | -38.3% | 0.00% | 0.0% |
| Q2 2017 | $425,000 | +36.7% | 48,100 | 0.0% | 0.00% | +50.0% |
| Q1 2017 | $311,000 | +75.7% | 48,100 | 0.0% | 0.00% | +100.0% |
| Q4 2016 | $177,000 | +13.5% | 48,100 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $156,000 | +39.3% | 48,100 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $112,000 | -6.7% | 48,100 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $120,000 | -18.9% | 48,100 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $148,000 | +78.3% | 48,100 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $83,000 | -57.4% | 48,100 | 0.0% | 0.00% | -50.0% |
| Q2 2015 | $195,000 | +6.0% | 48,100 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $184,000 | -20.3% | 48,100 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $231,000 | +29.1% | 48,100 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $179,000 | +1.7% | 48,100 | 0.0% | 0.00% | +100.0% |
| Q2 2014 | $176,000 | -13.3% | 48,100 | 0.0% | 0.00% | -50.0% |
| Q1 2014 | $203,000 | -8.1% | 48,100 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $221,000 | -25.8% | 48,100 | 0.0% | 0.00% | -33.3% |
| Q3 2013 | $298,000 | +13.7% | 48,100 | 0.0% | 0.00% | +50.0% |
| Q2 2013 | $262,000 | – | 48,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 4,750,000 | $112,433,000 | 20.02% |
| Avoro Capital Advisors LLC | 17,714,461 | $419,301,000 | 16.14% |
| Foresite Capital Management III, LLC | 2,541,729 | $60,163,000 | 12.96% |
| Foresite Capital Management IV, LLC | 1,231,543 | $29,151,000 | 9.94% |
| Ghost Tree Capital, LLC | 1,250,000 | $29,588,000 | 8.71% |
| NEXTHERA CAPITAL LP | 1,329,104 | $31,460,000 | 4.87% |
| RA Capital Management | 3,119,778 | $73,845,000 | 4.79% |
| DLD Asset Management, LP | 2,682,100 | $63,458,000 | 4.78% |
| Palo Alto Investors LP | 4,803,364 | $113,696,000 | 4.54% |
| DLD Asset Management, LP | 2,411,600 | $57,058,000 | 4.30% |